I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InDex Pharmaceuticals Holding AB
Interest Income Expense Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Interest Income Expense
kr42.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Interest Income Expense
-kr115.2m
CAGR 3-Years
-23%
CAGR 5-Years
-133%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Interest Income Expense
kr56m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Interest Income Expense
-kr97.3m
CAGR 3-Years
-177%
CAGR 5-Years
-219%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Interest Income Expense
kr2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Interest Income Expense
kr2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Interest Income Expense?
Interest Income Expense
42.4m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Interest Income Expense amounts to 42.4m SEK.

What is InDex Pharmaceuticals Holding AB's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
399%

Over the last year, the Interest Income Expense growth was 399%.

Back to Top